showing virtual absence ofuptake by right liver lobe and increase on left laparotomy radiographs showed elevation of the left hemidiaphragm. Liver function gradually improved and twelve weeks after biopsy, liver scan showed only minimal uptake in the right hepatic lobe with markedly increased left lobe uptake. The enlarged left lobe was palpable 4 cm below the costal margin. Since discharge in June 1972, the patient has thrived and is tumour free. The platelet count rose to normal after 18 months and liver function is normal. The chest X-ray and liver scan remain unchanged (Figs l and 2).
Discussion
In the United Kingdom the incidence of clinically significant and severe tadiation hepatitis in children appears to be low. Most reported instances are confined to patients who receive irradiation primarily to the liver or the right renal bed. However, minor degrees of liver damage are being sought and found increasingly at dose levels of radiation considered to be within tissue tolerance. The role of actinomycin D and other drugs which are being given as part of the combined therapy programmes must be assessed in relation to the occurrence of radiation hepatitis (Teft et al. 1971) . There is good evidence that actinomycin D sensitizes the skin and gut to radiotherapy and increases the morbidity when radiation is directed to these tissues in animals pretreated with actinomycin D (D'Angio et al. 1959 , Concannon et al. 1969 .
The previously established tissue tolerance limits for irradiation have to be reviewed in the light of present multimodal anticancer therapy. This is particularly important in childhood malignant disease where good results are being obtained by the combined use of surgery, radio-therapy and chemotherapy. The timing of the therapeutic manceuvres in relation to each other may turn out to be far more critical than previously suspected. If simultaneous or sequential therapy is to remain the standard form of treatment, then careful monitoring of the vulnerable tissues and organs is essential. Unless damage to normal tissues is detected early and appropriate adjustments made, irreversible damage may be done and a permanent loss of growth incurred. The implications of this in childhood are exceedingly serious as ultimate well being depends on the harmony of growth of all tissues and organs. Treatment andprogress: Following admission her cedema increased and blood urea rose to a maximum of 140 mg/100 ml. She was started on prednisone 30 mg/day and a low protein diet (see Fig 1) . There was no significant improvement and prednisone was increased to 60 mg/day. Azathioprine 75 mg/day was added. After one week she developed hypertensive encephalopathy whichwas treated with methyldopa, hydrallazine and phenytoin. After one month she showed marked clinical improvement, the oedema had resolved, GFR rose to 51 ml min-im-', C, was rising and anti-DNA falling, but ANF remained strongly positive. After a further month she developed left trigeminal herpes zoster. Azathioprine was stopped and prednisone reduced to 30 mg/day. Idoxuridine was applied topically and she recovered after one week.
After a total of four months treatment with azathioprine GFR was 62.5 ml min-' m-2, anti-DNA 26 %, C3 and C4 normal, ANF still strongly positive. Prednisone was gradually reduced to 12 mg/day. Eight months after azathioprine therapy began GFR was 110 ml min-'m-2, 24hour urinary protein output 5 g, plasma proteins 5.9 g/100 ml, and microscopic hiematuria persisted. Prednisone was increased to 22.5 mg/day in view of falling C3 and rising anti-DNA titre. There was no height increment since treatment had begun.
Comment
The first description of systemic lupus erythematosus (SLE) was by Kaposi (1872) , who mentioned the fever, the toxic state and the cutaneous manifestations. In 1895 Osler gave a full description of systemic involvement and first drew attention to cedema and nephropathy. In the largest series of SLE patients reported (Estes & Christian 1971 , Meislin & Rothfield 1968 ) over 50% were shown to have renal involvement though 5 % or less presented initially as cases ofrenal disease.
Diffuse proliferative glomerulonephropathy is one of the less common of the three forms of lupus nephritis (Estes & Christian 1971) . Our patient also showed other features including punctate lesions on the toes and hepatosplenomegaly, which occurs in 60% of childhood cases (Meislin & Rothfield 1968) but is unusual in adults. Diagnosis was made difficult by the fact that ANF as measured by the latex technique was negative on three occasions, but was strongly positive by the immunofluorescent technique; it is advised that the latter be used for diagnostic purposes in this disease. Also positive in our patient were VDRL (found in 29 % of cases) and direct Coombs test (found in 27%). Fig 1 shows initial investigations and response to treatment. C, complement rose to normal two weeks after starting azathioprine; changes in C4 levels generally corresponded, but were lower (the usual pattern in lupus nephritis). Anti-DNA antibody fell more gradually and there was a steady rise in glomerular filtration rate. Currently it remains within the normal range, and dosage I U44 5 of prednisone has been reduced to 12 mg on alternate days.
The use of cytotoxic agents is a recent advance in the treatment of lupus nephritis, and azathioprine, cyclophosphamide and chlorambucil have been used. They are antiinflammatory, appear to inhibit antibody/antigen complex formation and have the important advantage of allowing the dose of corticosteroids to be reduced. The principal danger associated with such drug combinations is the exacerbation of infection; in Estes & Christian's series 13 % of deaths were attributable to this cause. Our patient suffered a severe herpes zoster infection involving the mandibular division of the facial nerve; she made a good recovery but was very ill during this complication. Prognosis: Authorities differ as to whether childhood SLE carries a worse prognosis than the adult form. Meislin & Rothfield (1968) suggested that it did, but Merrell & Shulman (1955) and Estes & Christian (1971) do not confirm this. The renal involvment carries the poor prognosis; 37 % of deaths in Estes & Christian's series were due to this, and proliferative glomerulonephropathy was shown to carry the worst prognosis, with a 70 % five-year mortality in contrast to a 77 % fiveyear survival in the total SLE population. Baldwin et al. (1970) M C is the first child of healthy unrelated parents. Pregnancy was normal and delivery at term required forceps. His condition at birth was good, he weighed 3.6 kg and he was fully breast fed until 13 weeks. At 5 weeks of age, when in good general health and developing normally, he had his first convulsion.
At 9 weeks, following two further convulsions, he was admitted to hospital. Apart from a head circumference of 42.5 cm (>97th percentile) there was no abnormality. Serum calcium, 'Present address: Department of Child Health, City Hospital, Nottingham NG7 2RD cerebrospinal fluid, skull X-ray and EEG were normal. Subdural taps were negative. He was treated with phenobarbitone and phenytoin.
At 11 weeks of age he had a further convulsion and was readmitted. Further enlargement of the head was noted but there was no papilloedema or other abnormality on physical examination. An air encephalogram showed slight dilatation of the ventricular system but normal movement of air to the superior sagittat sinus. The convulsions became uncontrolled despite anticonvulsants. Investigation revealed a serum calcium of 4.5 mg/ 100 ml (normal 8.5-10.5) serum phosphorus 6.8 mg/100 ml (normal 4.0-5.5) and serum magnesium 0.79 mg/100 ml (normal 1.5-2.8). Treatment with calcium, vitamin D and small amounts of magnesium was started. A good initial biochemical response was achieved but the convulsions were only briefly controlled.
By the age of 13 weeks, cedema and diarrhaea had developed and convulsions were more frequent. The serum magnesium fell and a week later it was 0.2 mg/100 ml. The serum calcium was 6.9 mg/100 ml. The infant at this time was pale, cedematous and unresponsive with a positive Chvostek's sign and frequent generalized convulsions. Treatment with intravenous magnesium sulphate resulted in immediate control of the seizures. Anticonvulsants were discontinued.
Investigations: On admission, normal hematology, including prothrombin time, serum iron, folate and vitamin B12; total protein was reduced to 4.1 (albumin 2.6) g/100 ml.
Liver function tests, urea, electrolytes and full urine analysis were normal. Fat, carbohydrate and nitrogen absorption were within normal limits and a jejunal biopsy showed no abnormality on light microscopy.
A protein-losing enteropathy was demonstrated using 51CrC12, 11 % of the intravenously administered isotope being found in the stool over a five day collection (nonnal 1-2%).
EEG showed a severe diffuse abnormality consistent with a biochemical disturbaee..Skull X-ray: widening of sutures batf n othef bony abnormality. Serial parathormone estimations: 105,40,50,40 and 70 pg/ml (normal 100-200) . At the age of 4 months, a three-day magnesium balance was carried out while the patient was receiving intramuscular magnesium supplements. This demonstrated a positive magnesium balance, but with abnormally high fmcal magnesium (Fig 1) . Normal absorption ofingested magnesium is 55-75%. Serum levels were consistently subnormal.
Treatment and progress: Owing to profuse diarrhoea, magnesium supplements were initially given as intramuscular magnesium sulphate
